
Post

小米粥11
#ModernaQ3财报将揭示疫苗销售趋势 Moderna Q3是验证其呼吸道疫苗商业化转型的关键窗口。市场一致预期营收约8.9亿美元,收入重心由传统新冠疫苗,逐步向mNEXSPIKE新版新冠疫苗、RSV疫苗mRESVIA以及新获批mRNA流感疫苗mFLUSIVA切换。本次财报重点看三点:美国秋冬季新冠疫苗接种放量、RSV疫苗的市场份额,以及流感新品的初始铺货情况。新冠疫苗需求持续常态化承压,是最大拖累变量;如果流感与RSV疫苗销售不及预期,短期业绩会继续承压。管理层指引、新疫苗毛利率与海外订单,将决定股价短期方向。
Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
Trending crypto
BTC/USDTBitcoin
$61,700-0.02%
ETH/USDTEthereum
$1,748.56-0.02%
SOL/USDTSolana
$72.09-0.02%
Today’s market buzz
1#Anthropic launches IPO roadshow, valuation rebounds to $1.8 trillion
Hot


2#Twenty One Capital increased its holdings by 154 BTC, marking the first time since July 2025
3#Gold fell below $3745, wiping out nearly $800 billion in market value